The Cost Of Prescribing Direct Oral Anticoagulants (DOACS) There Is A Drug Cost But What Else?

Ann Kirby

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Value in Health
DOIs	https://doi.org/10.1016/j.jval.2017.08.574
Publication status	Published - 2017

Keywords

Medicine
Reimbursement
Atrial fibrillation
Intensive care medicine
Health care
Medical emergency
Internal medicine
Economics
Economic growth

Access to Document

10.1016/j.jval.2017.08.574

https://openalex.org/W2766956661Licence: CC BY-NC-ND

Cite this

@article{de1dcf78fe304e0da5fae0ff0f20c63d,

title = "The Cost Of Prescribing Direct Oral Anticoagulants (DOACS) There Is A Drug Cost But What Else?",

keywords = "Medicine, Reimbursement, Atrial fibrillation, Intensive care medicine, Health care, Medical emergency, Internal medicine, Economics, Economic growth",

author = "Ann Kirby",

year = "2017",

doi = "10.1016/j.jval.2017.08.574",

language = "English",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - The Cost Of Prescribing Direct Oral Anticoagulants (DOACS) There Is A Drug Cost But What Else?

AU - Kirby, Ann

PY - 2017

Y1 - 2017

KW - Medicine

KW - Reimbursement

KW - Atrial fibrillation

KW - Intensive care medicine

KW - Health care

KW - Medical emergency

KW - Internal medicine

KW - Economics

KW - Economic growth

U2 - 10.1016/j.jval.2017.08.574

DO - 10.1016/j.jval.2017.08.574

M3 - Article

SN - 1098-3015

JO - Value in Health

JF - Value in Health

ER -